Phathom Pharmaceuticals (PHAT) Stock Forecast & Price Target

PHAT$6.06-0.17 -2.73%
BiotechnologyValue StockGrowth Stock
Compare
Market cap$492.63MEnterprise value$445.13MRevenue (TTM)$274.88MMarket position—

Score

68
Bullish
Value
60
Quality
44
Growth
100

Phathom Pharmaceuticals, Inc. price target

PHAT
Low$10.00
Average$16.50
High$22.00
Upside vs current price+172.3%

The average target of $16.50 is +172.3% versus the current PHAT price of $6.06.

Phathom Pharmaceuticals, Inc. analyst ratings

RatingAnalysts
Strong buy2
Buy8
Hold1
Sell0
Strong sell0
ConsensusBuy

11 analysts cover PHAT.

Phathom Pharmaceuticals, Inc. EPS and revenue estimates

The estimate table for the Phathom Pharmaceuticals, Inc. keeps 2026 EPS $-0.74, 2027 EPS $0.66, and years with fewer than three analysts are not filled in.

Fiscal yearEPS estimateRevenue estimate
2026$-0.74$315.03M
2027$0.66$488.03M

Is Phathom Pharmaceuticals, Inc. a buy or sell?

Of the 11 analysts covering Phathom Pharmaceuticals, Inc., 10 rate it a buy (2 strong buy and 8 buy), 1 rates it a hold, and 0 rate it a sell (0 sell and 0 strong sell).

The PHAT consensus label is Buy, beside 10 buy-side ratings and 0 sell-side ratings.

The average target of $16.50 implies +172.3% versus the current price of $6.06.

the Phathom Pharmaceuticals, Inc. closes with 10 buy-side ratings and 0 on the sell side. The headcount is Buy.

Reading the Phathom Pharmaceuticals, Inc. forecast

Analysts are far apart on PHAT. The published low is $10.00, the average is $16.50, and the high is $22.00.

From today's $6.06 print, the PHAT average target is +172.3% away.

Most of the PHAT coverage agrees: 10 of 11 analysts are on the buy side, 1 is at hold, and 0 are on the sell side, and the published consensus is Buy.

PHAT targets have been marked up: $15.50 across the last month versus $13.75 across the last quarter.

PHAT coverage is thin at 11 analysts, and one revision moves the average.

Phathom Pharmaceuticals, Inc. forecast questions

What is the PHAT price target?

The published range for PHAT is $10.00 to $22.00, with an average of $16.50. That average is +172.3% versus the current price of $6.06.

Is Phathom Pharmaceuticals, Inc. a buy or sell?

Of the 11 analysts covering Phathom Pharmaceuticals, Inc., 10 rate it a buy, 1 rates it a hold, and 0 rate it a sell. The consensus is Buy, which for PHAT is 10 on the buy side, 1 at hold, and 0 on the sell side.

What is the EPS estimate for Phathom Pharmaceuticals, Inc.?

Analyst EPS estimates for Phathom Pharmaceuticals, Inc.: 2026 $-0.74, 2027 $0.66.

What is the revenue estimate for Phathom Pharmaceuticals, Inc.?

Analyst revenue estimates for Phathom Pharmaceuticals, Inc.: 2026 $315.03M, 2027 $488.03M.

How many analysts cover PHAT?

11 analysts cover PHAT. Their consensus on PHAT is Buy, across those 11.

PHAT price $6.06 -0.17 -2.73%

Insights · Forecast · Financials · Learn

Stocklytics home · Screener